BiotechTube
Home/Matricelf/Gil Hakim
GH

Gil Hakim

CEO

Matricelf

Therapeutic Areas

Spinal Cord InjuryTraumatic Brain InjuryStrokeMyocardial Infarction

Matricelf Pipeline

DrugIndicationPhase
Spinal Cord Injury (SCI) Neural BridgeSpinal Cord InjuryPreclinical
Stroke Neural TissueIschemic StrokePreclinical
Traumatic Brain Injury (TBI) ImplantTraumatic Brain InjuryPreclinical
Myocardial Infarction Cardiac PatchMyocardial InfarctionPreclinical

Leadership Team at Matricelf

AS
Alon Sinai, PhD
Co‑Founder, Deputy CEO & President
SR
Sigal Russo
CFO
PT
Prof. Tal Dvir, PhD
Co‑Founder, CSO
TH
Tamar Harel Adar, PhD
CTO
TB
Tal Ben Neriah
VP Operations
HS
Hadas Shoham Nissan
Director Clinical and Regulatory Affairs
View full Matricelf profile